Two Sigma Advisers’s Perspective Therapeutics CATX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.7M | Buy |
495,250
+249,800
| +102% | +$859K | ﹤0.01% | 1200 |
|
|
2025
Q1 | $523K | Buy |
245,450
+93,840
| +62% | +$200K | ﹤0.01% | 1758 |
|
|
2024
Q4 | $484K | Buy |
+151,610
| New | +$484K | ﹤0.01% | 1789 |
|
|
2024
Q2 | – | Sell |
-2,310
| Closed | -$27.5K | – | 2464 |
|
|
2024
Q1 | $27.5K | Sell |
2,310
-930
| -29% | -$11.1K | ﹤0.01% | 2385 |
|
|
2023
Q4 | $13K | Sell |
3,240
-20
| -0.6% | -$80 | ﹤0.01% | 2463 |
|
|
2023
Q3 | $8.92K | Sell |
3,260
-360
| -10% | -$985 | ﹤0.01% | 2347 |
|
|
2023
Q2 | $24.2K | Sell |
3,620
-560
| -13% | -$3.74K | ﹤0.01% | 2319 |
|
|
2023
Q1 | $26.7K | Sell |
4,180
-270
| -6% | -$1.72K | ﹤0.01% | 2501 |
|
|
2022
Q4 | $11K | Hold |
4,450
| – | – | ﹤0.01% | 2456 |
|
|
2022
Q3 | $10K | Sell |
4,450
-990
| -18% | -$2.23K | ﹤0.01% | 2480 |
|
|
2022
Q2 | $17K | Sell |
5,440
-1,140
| -17% | -$3.56K | ﹤0.01% | 2561 |
|
|
2022
Q1 | $24K | Buy |
6,580
+2,620
| +66% | +$9.56K | ﹤0.01% | 2653 |
|
|
2021
Q4 | $15K | Buy |
+3,960
| New | +$15K | ﹤0.01% | 2557 |
|
|
2021
Q2 | – | Sell |
-5,170
| Closed | -$56K | – | 2468 |
|
|
2021
Q1 | $56K | Buy |
+5,170
| New | +$56K | ﹤0.01% | 2494 |
|